Sarah E. Hudelson - Concepedia

Author

Sarah E. Hudelson

Also Known As

De Bruyn, Guy, Hosseinipour, M.C., Nhando, Nehemiah, Piwowar-Manning, Estelle, S E Hudelson, S.E. Hudelson, Sarah E Hudelson, Sarah E. Hudelson, Sarah Hudelson, Sarah E. Hudelson

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Fred Hutch Cancer Center University of North Carolina at Chapel Hill Family Health International 360

About

Sarah E. Hudelson is an author at Johns Hopkins University specializing in hiv, medicine, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	357
2	Epidemiology	4	4	138
3	Public Health	3	3	110
4	Social Sciences	1	1	15
5	Family Medicine	1	1	15

Sarah E. Hudelson

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Antiretroviral Therapy for the Prevention of HIV-1 Transmission Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, New England Journal of Medicine	2016	1.7K
Nevirapine (NVP) Resistance in Women with HIV‐1 Subtype C, Compared with Subtypes A and D, after the Administration of Single‐Dose NVP Susan H. Eshleman, Donald R. Hoover, Shu Chen, The Journal of Infectious Diseases	2005	159
Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial Susan H. Eshleman, Sarah E. Hudelson, Andrew D. Redd, The Journal of Infectious Diseases	2011	109
Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns Susan H. Eshleman, Donald R. Hoover, Shu Chen, AIDS PharmacotherapyAntiviral DrugDrug ResistanceContraceptionNevirapine Resistance	2005	104
Prevention of HIV-1 Infection with Early Antiretroviral Therapy for the HPTN 052 Study Team* Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, Hptn 052Early Antiretroviral TherapyTreatment And PreventionHuman RetrovirusAntiviral Therapy	2011	86
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial Rami Kantor, Laura Smeaton, Saran Vardhanabhuti, Clinical Infectious Diseases	2015	78
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial Susan H. Eshleman, Sarah E. Hudelson, Andrew D. Redd, JAIDS Journal of Acquired Immune Deficiency Syndromes Sexual HealthAntiretroviral TherapyPreventive MedicinePartner InfectionsTreatment And Prevention	2016	75
Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of Life Mark Mirochnick, Taha E. Taha, Régis Kreitchmann, JAIDS Journal of Acquired Immune Deficiency Syndromes	2013	65
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection Susan H. Eshleman, Marla Husnik, Sarah E. Hudelson, AIDS	2007	59
Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT Mariya V. Sivay, Maoji Li, Estelle Piwowar‐Manning, JAIDS Journal of Acquired Immune Deficiency Syndromes	2017	50

Page 1